Modulating p75 neurotrophin receptor signaling as a therapeutic strategy for Huntington’s disease
Frank Longo - George E. and Lucy Becker Professor in Medicine and Professor (by courtesy) of Neurosurgery
Bio-X Affiliated Faculty
Dr. Longo's research group is focused on the discovery of cellular signaling mechanisms that serve as a basis for the development of novel therapeutic approaches for Alzheimer's disease, Huntington's disease and other neurological disorders.
Stanford Bio-X Seed Grants
Enhancement of Neuron: Device Interactions by Surface Presentation of Small Molecule Neurotrophin Receptor Agonists
Interdisciplinary Initiatives Program Round 3 – 2006
Research News
Study reveals immune driver of brain aging
January 20, 2021 - Stanford Medicine News Center
Scientists led by Stanford Bio-X affiliated faculty members Katrin Andreasson, Frank Longo, Irv...
5 Questions: Frank Longo on Alzheimer's, new neuroscience center
February 17, 2016 - Stanford Medicine News Center
In a recent interview, neurologist and Bio-X affiliate Frank Longo discussed Alzheimer’s disease...
Looking for origins of Alzheimer’s disease to find a treatment
August 15, 2014 - Stanford Medicine News Center
Scientists including Bio-X Director Carla Shatz and Bio-X affiliated faculty Frank Longo, Ben...